Vascular dysfunction in Huntington's disease is located at the blood-CSF barrier and is rescued by sphingosine-1-phosphate receptor agonist
Krzysztof Kucharz, Rana Soylu-Kucharz, Martine Saint‐Pierre…·Martin Lauritzen
This study identifies vessel-type-specific vascular barrier dysfunction in Huntington's disease and shows partial rescue with an S1PR1 agonist.